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Structural imaging studies of borderline personality disorder (BPD) have found regions of
reduced cortical volume, but these have varied considerably across studies. Reduced hip-
pocampus and amygdala volume have also been a regular finding in studies using conven-
tional volumetric measurement. How far comorbid major depression, which is common in
BPD and can also affect in brain structure, influences the findings is not clear.
Methods
Seventy-six women with BPD and 76 matched controls were examined using whole-brain
voxel-based morphometry (VBM). The hippocampus and amygdala were also measured,
using both conventional volume measurement and VBM within a mask restricted to these
two subcortical structures. Lifetime history of major depression was assessed using struc-
tured psychiatric interview.
Results
At a threshold of p = 0.05 corrected, the BPD patients showed clusters of volume reduction
in the dorsolateral prefrontal cortex bilaterally and in the pregenual/subgenual medial frontal
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cortex. There was no evidence of volume reductions in the hippocampus or amygdala,
either on conventional volumetry or using VBM masked to these regions. Instead there was
evidence of right-sided enlargement of these structures. No significant structural differences
were found between patients with and without lifetime major depression.
Conclusions
According to this study, BPD is characterized by a restricted pattern of cortical volume
reduction involving the dorsolateral frontal cortex and the medial frontal cortex, both areas
of potential relevance for the clinical features of the disorder. Previous findings concerning
reduced hippocampus and amygdala volume in the disorder are not supported. Brain struc-
tural findings in BPD do not appear to be explainable on the basis of history of associated
lifetime major depression.
Introduction
Borderline personality disorder (BPD) is characterized by identity disturbance, unstable and
intense interpersonal relationships, impulsive and self-damaging behavior, anger dyscontrol,
affective instability, problems tolerating being alone, and chronic feelings of emptiness [1,2].
Transient and stress-related psychosis-like manifestations are also a recognized feature of the
disorder [3] and a proportion of patients have more enduring psychotic symptoms, especially
hallucinations [4,5]. A clinical association with major affective disorder is increasingly recog-
nized [6–8], with up to 80% of patients meeting criteria for major depressive disorder at some
point in their lives [9]; and approximately 20% meeting criteria for bipolar I or II disorder
[10]. A link with post-traumatic stress disorder has been proposed but is currently not
unequivocally established [11].
Biological factors in BPD are a focus of considerable current interest, with genetic, neuroen-
docrine and brain imaging studies all reporting positive findings [2,12,13]. Structural imaging
studies in particular have implicated the amygdala and hippocampus, with reduced volume of
these structures being found in two meta-analyses [14,15]. Cortical volume reductions have
also been found in studies examining selected regions of interest (ROIs), including in the ante-
rior cingulate cortex, the orbitofrontal cortex and the right parietal cortex [16–19].
Around 10 studies to date have also examined brain structure in BPD using voxel-based
morphometry (VBM) [20]. This technique has advantages over conventional brain volume
measurement in that it examines across the whole brain and so can detect changes that may be
small and/or do not correspond to accepted anatomical subdivisions. The majority of these
studies have been small (range 7–34 patients and corresponding numbers of controls),
although two recent studies compared 68 patients and 52 controls [21] and 60 patients and 60
controls [22], respectively. A meta-analysis of these studies [23] found support for volume
reductions in the pars opercularis and triangularis of the right inferior frontal gyrus, and in
parts of the temporal lobe cortex bilaterally, and less robustly in the precentral gyrus and the
right superior frontal gyrus. Volume increases were found in the right cerebellum, the right
supplementary motor area, the left rolandic operculum and the right middle frontal gyrus.
This meta-analysis also found pooled evidence for volume reductions in the right hippocam-
pus, and less robustly in the left hippocampus using VBM.
VBM in BPD
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Both major depression [24,25] and bipolar disorder [26–28], are known to be associated
with cortical volume reductions. Reduced volume of the hippocampus is also a feature of
major depression [24], and has recently been found in bipolar disorder as well in a large study
[29].
Nevertheless, whether this is a factor relevant to the brain structural findings in BPD has
been examined in relatively few studies, either using conventional volumetric measurement
[16,17,30,31] or VBM [32,33]. Nor was history of affective disorder examined as a moderating
factor in the above meta-analysis of voxel-based studies [23].
In the present study we aimed to evaluate brain structural abnormalities using VBM and
whole-brain analysis in a relatively large sample of patients with BPD and well-matched
healthy controls. We examined hippocampal and amygdala volume using both voxel-based
and conventional measurement techniques. Additionally, we considered the question of to
what extent any brain structural differences from controls found might be related to history of
major depressive disorder in the patients.
Material and methods
Subjects
Seventy-six female out-patients with BPD were recruited from two hospitals in Barcelona with
specialized units for the disorder: Hospital de la Santa Creu i Sant Pau and the Consorci Sani-
tari de l’Anoia. Participants were recruited from December 2010 to September 2011. Although
a small number of men were also seen over this period, it was decided not included them in
order to avoid the potential noise due to normal gender differences in brain structure [34].
Inclusion criteria were: 1) diagnosis of BPD made according DSM-IV criteria; this was
made on the basis of the Spanish version of the Structured Clinical Interview for DSM-IV Axis
II Personality Disorders (SCID II) [35]; patients were also required to score above the cutoff
(score 6) on the Spanish Revised Diagnostic Interview for Borderlines [36] (DIB-R). 2) age
between 18 and 55 years, 3) right-handed; and 4) having an IQ in the normal range (based on
available clinical information plus an IQ-estimate based on two subsets of the WAIS-III:
Vocabulary and Matrix Reasoning).
Exclusion criteria included: IQ under 70, a history of brain trauma (as indexed by skull frac-
ture, loss of consciousness for more than 24 hours or presence of post-traumatic amnesia) or
neurological disease, or having shown alcohol/substance abuse or dependence within the six
months prior to participation. Patients were assessed for presence of other mental disorders,
specifically schizophrenia, schizoaffective disorder, bipolar disorder and major depressive dis-
order,using the lifetime version of the Structured Clinical Interview for DSM-IV (SCID-I)
[37]. Any who had a history of schizophrenia, schizoaffective disorder or bipolar disorder were
excluded. Those with a history of major depressive disorder were not excluded, but presence
of such episodes was recorded (see below). Patients with current major depression were
excluded.
Forty-one of the patients were on psychotropic medication. Twenty-one were taking anti-
depressants (12 with adjunctive mood stabilizer, 9 without mood stabilizer). Four patients
were taking antipsychotics (2 with adjunctive mood stabilizer, 2 without mood stabilizer).
Seven patients were treated with both, antidepressants and antipsychotics (6 with adjunctive
mood stabilizer, 1 without mood stabilizer). Seven patients were on mood stabilizers alone.
The control sample consisted of 76 right-handed healthy women selected to be age and IQ-
matched to the patients. They were recruited from non-medical staff working in a hospital
(Benito Menni CASM), their relatives and acquaintances, and also from sources in the com-
munity who were recruited by advertisement, and word of mouth. They met the same
VBM in BPD
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exclusion criteria as the BPD group. They were interviewed by a clinical psychologist or psy-
chiatrist and were excluded if they reported a history of any psychiatric disorder or were taking
any type of psychotropic medication other than non-regular use of benzodiazepines or other
similar drugs for insomnia. They were also questioned about family history of mental illness
and excluded if a first-degree relative had experienced symptoms consistent with major psy-
chiatric disorder.
The study was carried out in accordance with the latest version of the Declaration of Hel-
sinki and was approved by the relevant research ethics committee (Comité Ético de Investiga-
ción Clı́nica de las Hermanas Hospitalarias, Barcelona). Written informed consent was
obtained for all subjects. The participants did not receive any economic compensation.
Clinical assessment
All patients were assessed by clinical psychologists who were experienced in the evaluation
and treatment of BPD. Symptom measures included: 1) The Structured Clinical Interview for
DSM-IV Axis II Personality Disorders (SCID-II) [35,38]. 2) The Spanish version of the Revised
Diagnostic Interview for Borderlines (DIB-R) [36]. This is a semi-structured interview, which
assesses features of BPD over the last two years. The Spanish version has shown good psycho-
metric properties regarding internal consistency (Cronbach’s alpha: 0.89), inter-rater reliabil-
ity (within-class correlation: 0.94), sensitivity (0.81), and specificity (0.94). 3) The Spanish
version of Borderline Symptom List– 23 (BSL-23) [39,40]. This is a self-rating instrument used
to assess the type and severity of symptoms seen in BPD. It represents a shortened form of
BSL-95, and includes 23 items from the original 95 that have high sensitivity to change and
high ability to discriminate BPD from other pathologies. We used a validated Spanish version
with good psychometric properties in terms of total internal consistency (Cronbach’s alpha:
0.936), one-week temporal reliability (r = 0.73), correlation with DIB-R scores and discrimina-
tion among different levels of BPD severity. For technical reasons it was only possible to carry
out the BSL-23 on 54 patients.
Presence or absence of comorbid major depressive disorder was established from the life-
time SCID-I [37].
Image acquisition and pre-processing
All subjects underwent a single MRI scanning session using a 1.5 Tesla GE Signa scanner
(General Electric Medical Systems, Milwaukee, Wisconsin) located at the Sant Joan de Déu
Hospital in Barcelona (Spain). High resolution structural T1 MRI data were acquired with the
following acquisition parameters: matrix size 512x512; 180 contiguous axial slices; voxel reso-
lution 0.47x0.47x1 mm3; echo (TE), repetition (TR) and inversion (TI) times, (TE/TR/TI) =
3.93 ms/2000 ms/710 ms respectively; flip angle 15 degrees.
Whole-brain analysis
Structural data was analyzed with FSL-VBM [41], http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/
FSLVBM), an optimized VBM protocol [42] carried out with FSL tools [43]. This method
takes TIV into account. First, structural images were brain-extracted and gray matter-seg-
mented before being registered to the MNI 152 standard space using non-linear registration
[44]. The resulting images were averaged and flipped along the x-axis to create a left-right sym-
metric, study-specific gray matter template. Secondly, native gray matter images were non-lin-
early registered to this study-specific template and ‘modulated’ to correct for local expansion
(or contraction) due to the non-linear component of the spatial transformation. The modu-
lated gray matter images were then smoothed with an isotropic Gaussian kernel with a sigma
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of 4 mm. Finally, voxelwise GLM was applied using permutation-based non-parametric test-
ing, correcting across space using the ‘threshold-free cluster enhancement’ (TCFE) method
[45].
Group comparison of gray matter VBM images was carried out by fitting general linear
models. Statistical significance was assessed through permutation-based non-parametric tests
(the randomize function in FSL) [46]. Correction for multiple comparisons was performed
using a TCFE FWE-corrected p-value of 0.05.
ROIs based on clusters where there were significant differences between the patients and
the controls in the whole brain analysis were extracted and used to examine associations with
clinical features (severity of borderline symptomatology and history of major depressive
disorder).
Analysis of hippocampal and amygdala volume
To compare hippocampal and amygdala volumes between groups we defined ROIs for these
two structures using the Harvard-Oxford Subcortical atlas provided in the FSL package. Mean
volumes for each subject in these ROIs were extracted from the individual GM-maps using
FIRST [47], a model-based segmentation/registration tool part of FSL [43] that measures the
volume of thalamus, caudate nucleus, putamen, pallidum, nucleus accumbens, hippocampus
and amygdala. Volumes were calculated for the left and right hippocampal and amygdala sepa-
rately and compared between groups using two-tailed t-test to test for differences. Results are
presented uncorrected and also corrected for multiple comparisons; given that the volumes
would be expected to be independent of each other, Benjamini and Yekutieli’s False Discivery
Rate (FDR) for non-independent variables [48] is more appropriate than Bonferroni correc-
tion here.
As well as absolute volumes, normalized volumes (i.e. absolute volume divided by overall
brain volume) were calculated. Normalized volumes provide a more sensitive measure of
regional brain volume differences (for a review see [49]). Overall brain volume was calculated
using SIENAX, part of FSL (www.fmrib.ox.ac.uk/fsl/) [50]. It should be noted that for normal-
ized analysis, to be valid, there should be no difference in mean overall brain volume between
the patient and control groups.
For completeness, and to make our examination comparable with previous studies, we also
carried out a VBM analysis within the hippocampus and amygdala structure. The VBM
approach was identical to the whole-brain FSL-VBM analysis but using a binary mask encom-
passing the amygdala and hippocampus bilaterally. Results were thresholded at t>2.3 and
TCFE corrected at p< 0.05.
Results
Demographic and clinical data
Demographic data on the patients and controls are shown in Table 1. The two groups were
well-matched for age and IQ.
Thirty-nine of the patients had a lifetime history of major depressive disorder and 37 did
not. There were no differences between these two patient groups in age (33.02±6.99 vs 31.10
±6.93, t = 1.19, p = 0.23, d.f. = 74), IQ (98.35± 4.20 vs 97.51±15.19, t = 0.25, p = 0.80, d.f. = 74),
or in DIB-R (7.79±1.10 vs 7.75±1.25, t = 0.42, p = 0.67, d.f. = 74) and BSL-23 scores (55.40
±23.80 vs 34.91±26.01, t = 1.64, p = 0.10, d.f. = 74).
Twenty-four of the BPD patients (31.15%) had no comorbid personality disorder (SCID II
data were missing for 6 patients). Twenty-three (30.26%) had one comorbid personality disor-
der, most frequently showing passive-aggressive, dependent-depressive or paranoid features.
VBM in BPD
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Fourteen (18.42%) had two comorbid personality disorders. Eight (10.52%) had three comor-
bid personality disorders. Two patients (2,60%) of 76 patients had four comorbid personality
disorders. Further details are shown in the Supplementary Material, S5 Table.
Whole-brain VBM analysis
The findings are shown in Fig 1 (note: T-test maps are available in neurovault route: https://
neurovault.org/images/58125/). Compared to the healthy subjects, the patients with BPD
showed three clusters of gray matter reduction, all in the frontal cortex. A cluster of 1014 vox-
els was seen in the medial frontal cortex, located mostly subgenually, extending from the gyrus
rectus to the anterior cingulate gyrus and including part of the orbitofrontal cortex (peak at
[MNI: 2, 40, -14], BA 11, t = 4, p = 0.01). There were also two roughly symmetrical clusters in
the lateral frontal cortex, (left: 341 voxels peak at [MNI: -38, 46, 4], BA 47, t = 3.12, p = 0.02;
right: 66 voxels, peak at [MNI: 30, 50, 2], BA 47, t = 3.61, p = 0.04).
Relationship of changes found in the whole brain analysis to clinical
features
A Shapiro-Wilk normality test was used to verify the normality of distribution of the BSL
scores (W = 0.96, p = 0.77) and gray matter volumes in the combined lateral ROI (W = 0.98,
p = 0.53) and the medial ROI (W = 0.99, p = 0.87). There was a significant negative correlation
between the BSL-23 score and mean volume in the combined lateral frontal ROI (r = -0.32;
p = 0.02). This remained significant after controlling for age (r = -0.41, p = 0.002) but became
insignificant after controlling for IQ (r = -0.16, p = 0.25). The correlation between BSL-23
score and the medial frontal ROI was not significant. There were no significant correlations
between DIB-R total score and mean volumes in either the medial frontal ROI (r = 0.14;
Table 1. Demographic and clinic characteristics of patients and controls. All comparisons are two-tailed. Data for IQ were missing from 6 patients and 6 healthy con-
trols (replaced by the group mean). BSL-23 scores were only available for 54 patients.
Patients (n = 76) Controls (n = 76) t-value
(d.f.)
P value
Age (years) 32.09±6.98 33.55±12.264 0.902
(150)
0.37
IQ 97.34 ± 13.90 98.86 ± 10.07 0.768
(144)
0.44
DIB-R total 7.82 ± 1.18 - -
BSL-23 total 55.48 ± 25.29 - -
Lifetime major depressive disorder present/absent 39/37 - -
https://doi.org/10.1371/journal.pone.0191946.t001
Fig 1. Whole-brain VBM comparison of the BPD patients and controls. Cluster of volume reduction in BPD
located in medial frontal cortex and in lateral frontal cortex. The right side of the image is the right side of the brain.
Slice labels from left to right z (MNI) = 23 -17 -13 -8 2 4.
https://doi.org/10.1371/journal.pone.0191946.g001
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p = 0.23) or the combined left and right lateral frontal ROIs (r = -0.06; p = 0.63). Scatter plots
are shown in Fig 2.
There were no differences in GM volume between patients with and without history of
MDD in either of the two ROIs (medial ROI: MDD mean = 0.48±0.06; no MDD
mean = 0.48 ± 0.05; t = -0.03; p = 0.97. combined lateral ROI: MDD mean = 0.42±0.05; no
MDD mean = 0.43±0.06; t = 0.70; p = 0.48).
Scatterplots of the mean volumes of the same two ROIs in the 11 patients who were taking
antipsychotic medication and the 65 who were not are shown in Supplementary Material, S1
Fig. It can be seen that there is no obvious tendency for the treated patients to have larger or
smaller volumes. Given the small number of treated patients statistical analysis was not consid-
ered feasible. Individual values are shown in Supplementary Material, S6 Table.
Hippocampal and amygdala volumes
Absolute volumes for these structures are shown in Table 2. The right amygdala was signifi-
cantly larger in the patients, but this difference became nonsignificant after FDR correction.
All other differences in absolute volumes were nonsignificant.
There was no difference in intracranial volume between the two groups (patients 1055784
±76261.7 mm3 vs controls 1069951±74217.98 mm3, t = 1.16; p = 0.25). Comparison of normal-
ized hippocampal and amygdala volumes again revealed enlargement in the right amygdala in
the patients, which became nonsignificant after FDR correction (see Supplementary Material,
S7 Table).
Fig 2. Scatter plots of correlations between: a) mean volume in the combined lateral frontal region and BSL-23
scores, b) mean volume in the medial ROI and BSL-23 scores.
https://doi.org/10.1371/journal.pone.0191946.g002
Table 2. Absolute volumes of hippocampus and amygdala (mm3) in the patients and controls. All p-values are two-tailed. All d.f. = 150.
Structure BPD (n = 76) Controls (n = 76) t p p-FDR corrected
Left amygdala 1044.70±165.21 1043.865±155.91 -0.03 0.97 0.97
Right amygdala 967.17±189.49 907.169±181.73 -1.99 0.048 0.19
Left hippocampus 3425.40±346.53 3510.55±364.28 1.48 0.14 0.28
Right hippocampus 3486.91±403.06 3536.23±356.68 0.80 0.43 0.57
https://doi.org/10.1371/journal.pone.0191946.t002
VBM in BPD
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There were no differences in absolute hippocampus volume between the patients with and
without a history of major depression (left: 3451.63±356.74 mm3 vs 3397.74± 338.10 mm3; t =
-0.67, p = 0.50; right: 3509.50±387.47 mm3 vs 3463.10± 422.90 mm3; t = -0.50, p = 0.62), or for
absolute amygdala volume (left: 1015.79±169.63 mm3 vs 1075.16± 156.93 mm3; t = 1.58,
p = 0.12; right: 970.86±188.24 mm3 vs 963.28 ± 193.32 mm3; t = 0.173, p = 0.86).(All d.f. = 74)
Results were similar using normalized volumes (see Supplementary Material, S8 Table).
VBM analysis masked to the hippocampal and amygdala ROIs revealed that, compared to
controls, patients showed clusters of increased gray matter volume in the right hippocampus
(120 voxels; peak at [MNI: 32, -22, -12], t = 4.43, p = 0.02) and in the right amygdala (53 voxels;
peak at [MNI: 22, -4, -24], t = 3.37, p = 0.03) (see Fig 3; note: T-test maps are available in neu-
rovault route: https://neurovault.org/images/58126/).
Scatterplots of the mean volumes hippocampal and amygdala ROIs in the 11 patients who
were taking antipsychotic medication and the 65 who were not are shown in Supplementary
Material, S1 Fig. Once again there is no obvious tendency for the treated patients to have larger
or smaller volumes. Given the small number of treated patients statistical analysis was not con-
sidered feasible. Individual values are shown in Supplementary Material, S6 Table.
Discussion
The present study, which applied whole-brain VBM with correction to a largest sample of
patients and controls, found volume decreases in the dorsolateral prefrontal cortex bilaterally
and the ventromedial frontal cortex, particularly the subgenual portion of this. Examination of
the hippocampus and amygdala using both conventional volume measurement and VBM
failed to confirm previous findings of volume reductions and, if anything, pointed to enlarge-
ment. Relationships between volume abnormalities and history of major depression were not
seen.
Our finding of volumetric abnormality in the dorsolateral prefrontal cortex could be con-
sidered to be consistent with the view that some of the clinical features of BPD, such as impul-
siveness and emotional instability reflect frontal lobe dysfunction. Neuropsychological and
functional neuroimaging studies of BPD have also been interpreted as supporting a basis for
the disorder in altered fronto-limbic function [2,51,52]. However, the neuropsychological
findings in BPD have been quite variable, and a meta-analysis did not find any clear evidence
for impairment on executive tasks [53]. Functional imaging studies using behavioral inhibition
tasks such as the Stroop test and the Go-No Go paradigm have mostly not found reduced pre-
frontal activations in BPD patients, although this has been demonstrated when an emotional
component has been incorporated into the tasks [54]. Our own finding that there was a signifi-
cant negative correlation between volume in this region and the BSL-23 score, is also open to
other interpretations, since it became insignificant when IQ was controlled for, in keeping
with studies that have found the volume of this regions to be associated with intelligence [55].
Our study did not find expected volume reductions in the amygdala or hippocampal vol-
ume in BPD. The absence of such a finding in the VBM comparison is not unexpected since,
for a number of methodological reasons, whole-brain VBM is less sensitive to volume alter-
ations in small subcortical structures than large cortical areas (eg see [56,57]). However, vol-
ume reductions in these structures were also not seen when ROI analysis were employed,
which instead found evidence for an increase in the right amygdala volume in the BPD
patients (although only significantly without correction for multiple comparisons). This find-
ing goes against two meta-analyses of ROI studies [14,15]. The reason or reasons for this dis-
crepancy are obscure, although the fact that our study was considerably larger than the studies
contributing to the two ROI-based meta-analysis might be important. VBM analysis masked
VBM in BPD
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to the hippocampus and amygdala also tended to support a finding of right-sided enlargement
in both structures. This was found to be restricted to a small area in both structures, something
that could reflect either a genuine localization of the enlargement, or alternatively could simply
be where a generalized enlargement was most marked and became suprathreshold.
There was little to suggest from our study that brain volume reductions in BPD are explain-
able in terms of co-existent major depression, which is itself associated with cortical and hip-
pocampal volume reductions [33]. Nevertheless, the pattern of cortical volume reductions we
found is not dissimilar to that seen in major depression. Thus, a meta-analysis of VBM studies
of major depressive disorder by Bora et al [25] found a single volume of volume reduction in
the medial frontal cortex. This was located more rostrally and closer to the genu of the corpus
callosum than the corresponding cluster in our BPD patients. When a less conservative thresh-
old was used, this cluster extended more rostrally and also into the subgenual anterior cingu-
late cortex. An additional cluster of volume reduction in the right dorsolateral frontal cortex
also appeared at this lower threshold.
One possible interpretation of this similarity is that the some of the brain structures affected
in both BPD and affective disorder are involved in the normal regulations of mood. Of rele-
vance here is a theoretical review by Price and Drevets [58]: they noted that the medial frontal/
orbitofrontal cortex has anatomical connections to the amygdala, ventral striatum and the
hypothalamus, and has also been found to show functional imaging changes in both major
depression and normal sadness. Accordingly, they argued that this cortical region is involved
in ‘forebrain modulation of visceral function in response to sensory or emotive stimuli’, some-
thing that could easily translate into a role in emotional and mood disorders in humans.
Some limitations of our study need to be acknowledged. First, some patients with BPD
were taking antipsychotic and antidepressant medication, something that has the potential to
affect brain structure, at least in the case of antipsychotics. Secondly, BPD is associated with
other comorbidities besides major affective disorder which may affect brain structure, includ-
ing alcohol/drug abuse [59,60] and also perhaps post-traumatic stress disorder, although this
last association is currently undecided [11]. We only excluded substance abuse within the six
prior months to participation but we did not examine patients for history of post-traumatic
stress disorder. Finally, in contrast to some but not all VBM studies of BPD, the healthy con-
trols in this study were not screened for presence of axis II disorders, ie personality disorders.
This might account for some of the heterogeneity among the findings to date.
Fig 3. Clusters of increased volume on VBM within the bilateral hippocampus/amygdala mask (mask shown in
green). Increased gray matter volume in right amygdala (p = 0.02) and right hippocampus (p = 0.03) is shown in
yellow. The right side of the image is the right side of the brain. Slices labels: z (MNI) -22 -20 -18 -16.
https://doi.org/10.1371/journal.pone.0191946.g003
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Fundació La Marató de TV3 (2009–092410) and two Miguel Servet Research Contract grants
(CP10/00596 to EP-C and CP13/00018 to RS) from the Plan Nacional de I+D+i and co-funded
VBM in BPD
PLOS ONE | https://doi.org/10.1371/journal.pone.0191946 February 21, 2018 10 / 14
by the Instituto de Salud Carlos III-Subdirección General de Evaluación y Fomento de la
Investigación and the European Regional Development Fund (FEDER).
Author Contributions
Conceptualization: Salvatore Aguilar-Ortiz, Pilar Salgado-Pineda, Juan C. Pascual, Joaquim
Soler, Cristina Brunel, Ana Martin-Blanco, Teresa Maristany, Salvador Sarró, Raymond
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Ribas, Teresa Maristany, Salvador Sarró, Raymond Salvador, Antoni Rodrı́guez-Fornells,
Edith Pomarol-Clotet, Peter J. McKenna.
Methodology: Salvatore Aguilar-Ortiz, Pilar Salgado-Pineda, Josep Marco-Pallarés, Juan C.
Pascual, Daniel Vega, Joaquim Soler, Cristina Brunel, Ana Martin-Blanco, Angel Soto, Joan
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13. Wingenfeld K, Spitzer C, Rullkötter N, Löwe B. Borderline personality disorder: hypothalamus pituitary
adrenal axis and findings from neuroimaging studies. Psychoneuroendocrinology. 2010; 35: 154–70.
https://doi.org/10.1016/j.psyneuen.2009.09.014 PMID: 19837517
14. Nunes PM, Wenzel A, Borges KT, Porto CR, Caminha RM, de Oliveira IR. Volumes of the hippocampus
and amygdala in patients with borderline personality disorder: a meta-analysis. J Pers Disord. 2009; 23:
333–45. https://doi.org/10.1521/pedi.2009.23.4.333 PMID: 19663654
15. Ruocco AC, Amirthavasagam S, Zakzanis KK. Amygdala and hippocampal volume reductions as can-
didate endophenotypes for borderline personality disorder: a meta-analysis of magnetic resonance
imaging studies. Psychiatry Res. 2012; 201: 245–52. https://doi.org/10.1016/j.pscychresns.2012.02.
012 PMID: 22507760
16. Brambilla P, Soloff PH, Sala M, Nicoletti MA, Keshavan MS, Soares JC. Anatomical MRI study of bor-
derline personality disorder patients. Psychiatry Res. 2004; 131: 125–33. https://doi.org/10.1016/j.
pscychresns.2004.04.003 PMID: 15313519
17. Irle E, Lange C, Sachsse U. Reduced size and abnormal asymmetry of parietal cortex in women with
borderline personality disorder. Biol Psychiatry. 2005; 57: 173–82. https://doi.org/10.1016/j.biopsych.
2004.10.004 PMID: 15652877
18. Lyoo IK, Han MH, Cho DY. A brain MRI study in subjects with borderline personality disorder. J Affect
Disord. 1998; 50: 235–43. PMID: 9858082
19. Hazlett EA, New AS, Newmark R, Haznedar MM, Lo JN, Speiser LJ, et al. Reduced anterior and poste-
rior cingulate gray matter in borderline personality disorder. Biol Psychiatry. 2005; 58: 614–23. https://
doi.org/10.1016/j.biopsych.2005.04.029 PMID: 15993861
20. Ashburner J, Friston KJ. Voxel-based morphometry—the methods. Neuroimage. 2000; 11: 805–21.
https://doi.org/10.1006/nimg.2000.0582 PMID: 10860804
VBM in BPD
PLOS ONE | https://doi.org/10.1371/journal.pone.0191946 February 21, 2018 12 / 14
21. Soloff PH, Pruitt P, Sharma M, Radwan J, White R, Diwadkar VA. Structural brain abnormalities and sui-
cidal behavior in borderline personality disorder. J Psychiatr Res. 2012; 46: 516–25. https://doi.org/10.
1016/j.jpsychires.2012.01.003 PMID: 22336640
22. Niedtfeld I, Schulze L, Krause-Utz A, Demirakca T, Bohus M, Schmahl C. Voxel-based morphometry in
women with borderline personality disorder with and without comorbid posttraumatic stress disorder.
PLoS One. 2013; 8: e65824. https://doi.org/10.1371/journal.pone.0065824 PMID: 23776553
23. Schulze L, Schmahl C, Niedtfeld I. Neural Correlates of Disturbed Emotion Processing in Borderline
Personality Disorder: A Multimodal Meta-Analysis. Biol Psychiatry. 2016; 79: 97–106. https://doi.org/
10.1016/j.biopsych.2015.03.027 PMID: 25935068
24. Arnone D, McIntosh AM, Ebmeier KP, MunafòMR, Anderson IM. Magnetic resonance imaging studies
in unipolar depression: systematic review and meta-regression analyses. Eur Neuropsychopharmacol.
2012; 22: 1–16. https://doi.org/10.1016/j.euroneuro.2011.05.003 PMID: 21723712
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